typically courteous help he had received from Sir Robert himself since he had taken up the Chair, Finally Dr J Alfred Lee spoke of Sir Robert's association with the Royal Society of Medicine, Sir Robert had been elected a Fellow in 1925: the Section of Anaesthesia was then 16 years old and the Section President was Dr Edmund Boyle. The list of speakers at that session was a distinguished one including, for example, Dr Ivan Magill, Dr E I McKesson of Toledo, Ohio, and Dr Henry Featherstone, founder of the Association of Anaesthetists of Great Britain and Ireland.
By 1947 the comparatively unknown anaesthetist had become one of the leaders of the speciality, notable for his emphasis on safety in anaesthesia, for pioneering simple apparatus which could be used in underdeveloped countries and in difficult situations, for fostering and taking part in scientific research in anaesthesia, for advocating the upgrading and adequate training of anaesthetists in foreign countries and for stimulating academic training in the speciality as Professor in the Nuffield Department at Oxford, the first fully endowed Chair in the subject in the world. It was not surprising, then, that, in 1947, he The Save a Life Campaign in which the Society has played a central part has been most successful and has been responsible for training 250 000 people in cardio-pulmonary resuscitation. His Royal Highness Prince Michael of Kent attended a demonstration of a training session at Wimpole Street and later presented awards to 15 people who had put their new found skills into practice. They attended together with the victims of cardiac arrest whom they had rescued.
In October I attended the centennial celebrations of the Italian Society of Internal Medicine in Rome, ably supported by Professor Derek Willoughby, Dr G F Bottazzo and Professor John Newsom-Davia at a joint session on auto-immune disease. The Italian society claims many great men of medicine among its past presidents and its history is one of solid support of scientific achievement. The Executive Director and I attended the Board meeting of the Royal Society of Medicine Foundation Inc. in New York in November. Our transatlantic division is most active in the promotion of links between our countries, most particularly in the exchange of 15 visiting professors each year and through our jointly organized Anglo-American meetings. Two of these meetings are in prospect and are to be held in London in September. The topics are 'AIDS' and 'Acute Pains which Persist'.
The Inaugural Meeting of the new Section of Clinical Forensic Medicine under its President Dr N Davis was held on 23 January, and got off to a fine start with a most interesting symposium on forensic aspects of fitness.
The Section of Medicine, Experimental Medicine and Therapeutics has been disbanded after several years of difficulties which appeared to arise out of diversification and different groupings of interest within medicine itself.
I must make special mention of two handsome bequests to the Society. A substantial donation was received in memory of the late Dr Manuel Lederman and it is fitting that the reading rooms on the mezzanine floor of the library have been named the Manuel Lederman rooms. The Society has benefited toofrom the great generosity ofthe late Dr E T Ruston
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Chronic muscle contraction headache: the importance of depression and anxiety Sir, It seems extraordinary that your journal should carry a paper on the use of diazepam and a very potent drug, flupenthixol, for the treatment of such a mild, though occasionally intractable, condition as chronic muscle contraction headache, as described by Hackett et al. (November 1987 JRSM, p 689) .
Surely, in 1988, we know better than to use powerful and, in the case of diazepam, habit-forming substances for the treatment of simple illnesses. There are plenty of people in medicine today who would not prescribe a benzodiazepine under any circumstances1.
It is now very clear that the many and varied reactions of individuals to 'life stress' are best not treated by pharmacological agents, but by one of the many alternative approaches. This being so, the publication of research papers on the evaluation of drugs in the indication of chronic muscle contraction is not helpful to the furtherance of good medical practice. The author replies below: Sir, A number of factors emerged during our investigation of patients with muscle contraction headache attending neurology clinics. Firstly, the consumption of over-the-counter analgesics was very high and in some cases, as many as 55 tablets per week were being taken. This is, of course, associated Journal of the Royal Society of Medicine Volume 81 July 1988 429 whose bequest has among other things provided the Society's in-house computer which handles our financial control and membership record systems. Finally, as this is my last President's letter I wish to thank the members of Council who have made my term of office so pleasant and easy to bear. Mr Bob Thomson has been a tower of strength at the administrative helm and over the past two years he has greatly improved the workings of the Society by his meticulous attention, not only to the broad spectrum of his duties but also to the minutiae of day to day management.
Sir Gordon Robson President Royal Society of Medicine
April 1988 with a high level of morbidity from peptic ulceration and gastrointestinal bleeding. We do not have to think very hard, in general practice, to find patients who have experienced such problems caused by the ingestion of such analgesics taken for 'mild' conditions. It was also of interest that of 40 patients attending our neurology clinic, 32 had previously been treated by their GP, with either a benzodiazepine or tricyclic analgesic for their muscle contraction headaches. At an initial review of the prescribing habits of the 3 consultants within the department, it was clearly found to be standard practice that when a serious cause for headache had been excluded, the patient was discharged to their GP, with a suggestion that a benzodiazepine be used to provide symptomatic relief. I share Dr Walden's concern about the overprescribing of benzodiazepines and, indeed, I think our paper serves to prove that they are ineffective agents with which to treat muscle contraction headache and, hopefully, further clinical evidence will result in their not being prescribed for this condition. In the paper, I did mention some of the many alternative approaches, but I am afraid the majority of neurologists who I have met, do not share Dr Walden's enthusiasm for such methods as biofeedback and relaxation techniques. Having gone through a period of enthusiasm for these therapies, I have found particularly in the north west of England, that it is very difficult to obtain the services of skilled biofeedback technicians and relaxation therapists and invariably when I do, the patient only attends on one or, at the most, two sessions. Likewise, tapes may be played a similar number of times and then discarded. Certainly Diamond in his 'Practising physicians' approach to headache' considers at great length pharmacological agents and acknowledges the reality of their place in prophylaxis, although for certain well motivated individuals, the techniques that Dr Walden considers, may be beneficial. I cannot see in my lifetime, that the supply of technicians in these fields will increase sufficiently to make them readily available for my patients and, I am sure, very little of the Government's injection of cash into the NHS, will be devoted to this field. It is, however, good to
